CVS sees 23% revenue growth in healthcare benefits & projects 10% EPS in 2025, with Aetna recovery boosting performance.

It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...

The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.

Pharmacy benefit managers take considerably different approaches to managing patient access to biosimilars, or cheaper ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case against their PBMs.

DeVaney led CVS Caremark sales and account management as president, Employer & Health Plans. CVS Health. This story was originally published on Supermarketnews. CVS ...

named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah, group president ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri ...